Online Matchmaking: EP PerMed Twinning Call 2026

25 Sept 2025 – 26 Feb 2026

Register
Register
Register

ExpertiseUpdated on 30 October 2025

Development and phenotyping of genetically engineered mouse models

Principal investigator at Izmir Biomedicine and Genome Center

Izmir, Türkiye

About

IBG Gene Targeting and Transgenic Models Platform has recently established its research laboratories and state of the art technological infrastructure. Our platform will provide services and collaborative support to internal and external researchers working in basic and translational biomedical sciences, whose work involve or require the generation of genetically-engineered mouse models.

In addition to the services we offer below, our lab is interested in investigating rare genetic disorders utilizing transgenic mouse models.

COLLABORATIVE SUPPORT AND SERVICES

Generation of knockout and knockin mouse models:

Our research platform invites researchers to collaborate with us for the generation of knockout and knockin mouse models for their favourite genes. We offer collaborations starting from initial planning and vector design stage to the final establishment of a genetically modified mouse colony.

We have, quite recently, created our first knockin mouse model for a new rare genetic disorder (see News tab). We are currently developing several transgenic disease models. We are ready to collaborate with interested partners who need to generate novel genetically modified mouse models.

Mouse embryo cryopreservation and rederivation:

The technological infrastructure for embryo cryopreservation and rederivation has been recently completed. After establishment of the relevant protocols, we will provide services to internal and external users who wish to store their transgenic mouse strains long term.

SERVICES - Currently provided

Services we currently provide are listed below. Please contact us via e-mail for further details, pricing and conditions of the services.

1. Knockout (indel)

2. Knockout (deletion)

3. Knockin (point mutations)

4. Knockin (epitope tags)

5. ESC gene targeting

6. Sperm cryopreservation

7. Embryo transfer and mouse strain rederivation

8. PNI (pronuclear injection)

9. IVF (in vitro fertilization)

Field

  • Receiver institution with a need to adopt a PM approach
  • Personalised treatment pathways (tailored therapies, precision dosing)
  • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
  • Theranostics (combined diagnostic + therapeutic approaches)

Organisation

Izmir Biomedicine and Genome Center

Research organisation

Izmir, Türkiye

Similar opportunities

  • Expertise

    Advancing Personalized Medicine Through Integrative Research and Clinical Excellence

    • Receiver institution with a need to adopt a PM approach
    • Clinical decision support systems for personalised medicine
    • Theranostics (combined diagnostic + therapeutic approaches)
    • Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Patient management systems (decision-support tools, clinical workflows)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
    • Cultural/organisational change approaches (staff training, workflow redesign)
    • Data integration & interoperability solutions (EHRs, registries, data platforms)
    • Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)
    • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
    • Patient engagement & empowerment strategies (self-management tools, shared decision-making)
    • Adaptation of an existing PM solution to local context (language, IT environment, regulations)
    • Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)

    Inês Costa

    Research Manager at Universidade de Coimbra - Faculdade de Coimbra

    Coimbra, Portugal

  • Expertise

    Secure Data Management & Analytics

    Seyma Gozuyilmaz

    Innovation Project Manager at Experilabs

    İstanbul, Kartal, Türkiye

  • Expertise

    Health Informatics

    • Clinical decision support systems for personalised medicine
    • Screening & early detection programs (risk stratification, predictive tools)
    • Cultural/organisational change approaches (staff training, workflow redesign)
    • Standardisation & evaluation methodologies (protocols, metrics, QA/QC processes)

    Arda Temena

    Health Informatician at Health Data & Policy Lab

    Istanbul, Türkiye